Close | |
![]() |
|
Figure 2: (a1) ENL lesions at baseline over the right cheek. (a2) ENL lesions at baseline over the left cheek. (b1) Complete clinical remission of ENL lesions following apremilast therapy as a standalone steroid-sparing drug (right cheek). (b2) Complete clinical remission of ENL lesions following apremilast therapy as a standalone steroid-sparing drug (left cheek) |
|